Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP... Read more
Consolidated Financial Statements for the Third Quarter Ended December 31, 2021 FY2022 (April 1, 2021-March 31, 2022) [UNAUDITED] | IR News | News Release ＆ IR News | Investor Relations Read more
Notice Concerning Forecast Revisions of Financial Results and Dividend (Dividend Increase) | IR News | News Release ＆ IR News | Investor Relations Read more
BOSTON – February 8, 2022 – GE (NYSE: GE) announced the appointment of Betty Larson as Chief People Officer of GE Healthcare effective March 1, 2022. Betty will be responsible for GE Healthcare’s Human Resources and Communications teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Betty will be a critical partner as we... Read more
Full-year organic growth, adjusted EBITDA margin expansion, adjusted earnings per share in line with November guidance Full-year revenue of $5.2 billion, up 7% on a reported basis, up 4% organically Full-year reported earnings per share of $2.35, up 68%; adjusted earnings per share of $2.49, up 21% Strong demand drives continuing commercial momentum in all... Read more
FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021. “Our first quarter results reflect continued execution of our BD2025 strategy and strong base business performance from all three segments.... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2021 financial results before market opening on Friday, February 11, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the... Read more
WALTHAM, Mass., Feb. 2, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 Highlights Fourth quarter revenue was $10.70 billion. Fourth quarter GAAP diluted earnings per share (EPS)... Read more
4Q Revenue of $1.36 billion; 1% reported growth; -9% organic growth 4Q GAAP EPS from continuing operations of $1.41; Adjusted EPS of $2.56 Initiates First Quarter and Full Year 2022 Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 1, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more
MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Tuesday, February 15, 2022, at 4:30 pm Eastern Time. The call will be webcast live and may be accessed at Pacific... Read more